First human clinical trial to test precision form of FLASH proton therapy
A new form of proton therapy—designed to deliver cancer-killing radiation therapy in less than a second, through fewer sessions, with potentially less risk of damaging side effects—is now being tested in a phase 1 clinical trial at the Abramson Cancer Center of the University of Pennsylvania. Known
<p>A new form of proton therapy—designed to deliver cancer-killing radiation therapy in less than a second, through fewer sessions, with potentially less risk of damaging side effects—is now being tested in a phase 1 clinical trial at the Abramson Cancer Center of the University of Pennsylvania. Known </p>